X
19
Biogen, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA and WHO-GMP.
One of their notable products is DACLIZUMAB, with a corresponding application number 761029.
With a dosage strength 150MG/ML
Dosage Form Route INJECTABLE; INJECTION